All Comments by Paul Coleman

  1. [Medical comorbidity in elderly patients with dementia. Differences according age and gender].
  2. Neuronal binucleation in Alzheimer disease hippocampus.
  3. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.
  4. Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death.
  5. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.
  6. The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia.
  7. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
  8. 8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease.
  9. Beta-amyloid burden is not associated with rates of brain atrophy.
  10. Amyloid beta oligomers induce impairment of neuronal insulin receptors.
  11. Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype.
  12. Cortical plasticity in Alzheimer's disease in humans and rodents.
  13. On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
  14. Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells.
  15. Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms.